May 3, 2017 (Waterloo, ON) – Intellijoint Surgical® is pleased to welcome Dr. Michael Bradley, MD, MBA, MS, as the newest member to its Scientific Advisory Board (SAB). Dr. Bradley is Chief of Orthopaedics at South County Hospital in Wakefield, Rhode Island, and President/CEO of Ortho Rhode Island. As a board-certified surgeon, he brings 12 years of orthopaedic surgical experience and a specialization in Direct Anterior (DA) Total Hip Arthroplasty (THA) to an already prolific and diversely skilled SAB.
“By joining Intellijoint Surgical’s SAB, I am excited to have a direct impact on the current and next generation of innovative navigation products improving surgical accuracy intraoperatively and patient outcomes post-operatively,” said Dr. Bradley. “I look forward to sharing my expertise during product development and providing market guidance.”
Dr. Bradley enjoys knowledge-sharing by teaching medical education courses in the US for knee, shoulder, and hip, and serves on the Health Policy Committee for the Arthroscopy Association of North America (AANA). Additionally, Dr. Bradley is an official University of Rhode Island (URI) athletic department surgeon and, when not caring for patients, enjoys cycling, paddle boarding, and playing soccer.
“Dr. Bradley was a key player in developing the recently FDA cleared intellijoint HIP® Anterior and will continue to be a great asset in guiding the development of future applications for hip replacements and other orthopaedic procedures,” commented Armen Bakirtzian, CEO and Co-Founder, Intellijoint Surgical.
Other surgeons of Intellijoint Surgical’s SAB include: Chairman, Dr. Allan Gross, an orthopaedic surgeon at Mount Sinai Hospital (Toronto, ON), and members, Dr. Javad Parvizi at Thomas Jefferson University Hospital (Philadelphia, PA), Dr. Michael Cross at Hospital for Special Surgery (New York, NY), Dr. Wayne Paprosky at Rush University Medical Center (Chicago, IL), and Dr. Ran Schwarzkopf at NYU Langone’s Hospital for Joint Diseases (New York, NY).